Aurinia Pharmaceuticals (AUPH) Change in Receivables (2020 - 2026)
Aurinia Pharmaceuticals (AUPH) posted Change in Receivables of $7.7 million for Q1 2026, down 28.02% on a QoQ basis from $10.7 million in Q4 2025, and up 102.86% year-over-year from $3.8 million in Q1 2025.
Aurinia Pharmaceuticals (AUPH) Change in Receivables (2020 - 2026) Analysis & Trends
Aurinia Pharmaceuticals' Change in Receivables history runs 7 years deep, the most recent figure standing at $7.7 million for Q1 2026.
- Quarterly Change in Receivables rose 102.86% year-over-year to $7.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.8 million (down 22.87% YoY) and the FY2025 annual result came in at $4.9 million, down 60.58% from the prior year.
- Change in Receivables was $7.7 million for Q1 2026 at Aurinia Pharmaceuticals, down from $10.7 million in the prior quarter.
- Across five years, Change in Receivables topped out at $23.6 million in Q3 2022 and bottomed at -$28.3 million in Q4 2022.
- A 5-year average of $2.0 million and a median of $3.8 million in 2025 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2024 — Change in Receivables plunged 841.14% — and 2025, when it soared 17483.61%.
- Aurinia Pharmaceuticals' Change in Receivables stood at -$28.3 million in 2022, then surged by 51.01% to -$13.9 million in 2023, then soared by 100.44% to $61000.0 in 2024, then surged by 17483.61% to $10.7 million in 2025, then fell by 28.02% to $7.7 million in 2026.
- Business Quant data shows AUPH's Change in Receivables at $7.7 million in Q1 2026, $10.7 million in Q4 2025, and -$9.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Aurinia Pharmaceuticals | 2.02 Bn | 1.64 Bn | 71.20 Mn | 7.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.72 Mn |
| Mar 31, 2026 | 7.72 Mn |
| Dec 31, 2025 | 10.73 Mn |
| Dec 31, 2025 | 10.73 Mn |
| Sep 30, 2025 | -9.36 Mn |
| Sep 30, 2025 | -9.36 Mn |
| Jun 30, 2025 | -259,000.00 |
| Jun 30, 2025 | -259,000.00 |
| Mar 31, 2025 | 3.81 Mn |
| Mar 31, 2025 | 3.81 Mn |
| Dec 31, 2024 | 61,000.00 |
| Dec 31, 2024 | 61,000.00 |
| Sep 30, 2024 | 10.96 Mn |
| Sep 30, 2024 | 10.96 Mn |
| Jun 30, 2024 | -3.39 Mn |
| Jun 30, 2024 | -3.39 Mn |
| Mar 31, 2024 | 4.82 Mn |
| Mar 31, 2024 | 4.82 Mn |
| Dec 31, 2023 | -13.86 Mn |
| Dec 31, 2023 | -13.86 Mn |